We identify purpose driven healthcare business models which provide superior clinical care and broad access to healthcare with a goal of improving patient outcomes.
WHAT:
We partner with our portfolio companies to create long-term value through sustainable healthcare focused business models which strive to deliver top quartile returns for our investors.
HOW:
We endeavor to execute this mission through transparency, judgement and the utilization of industry leading resources to enhance the performance of our portfolio company investments.
- Post-Acute Care
- Value-Based Care & Payer Services
- Women’s & Children’s Health
- Behavioral Health
- Pharma Services
(1) These priorities are aspirational in nature, and have not yet been accomplished. ³Ô¹Ï±¬ÁÏ is permitted to determine in its discretion that it is not feasible or practical to implement or complete all or any investments in these sectors and goals based on cost, timing, or other considerations. There is no guarantee that ³Ô¹Ï±¬ÁÏ will make investments in companies that meet these outcomes.
- Targeting both organic and acquisition-based product and service expansion
- Utilize ³Ô¹Ï±¬ÁÏ Operating Executives to partner with management and build high performing companies
- Work with management to establish strategic objectives
- Identify and implement performance metrics and best practices across key value drivers
- Mission critical, patient-centric businesses
- Control investor
- Typically first institutional capital
- Focus out of favor and new sectors
- EBITDA at entry: $5-$20M+
- Maintain strong governance
- Embed material ESG factors in investment process and decisions
- Active ESG stewardship
- Foster transparency, accountability and shared responsibility
NOTES: Our ESG policies may not apply in every case and are subject to change.